Compounds derived from 5.1 imidazo [- F] [1,2,4] Triazines, Pharmaceutical Composition and use in the treatment of cognitive impairment associated with schizophrenia.
CHAPPIE THOMAS ALLEN,HUMPHREY JOHN MICHAEL,VERHOEST PATRICK ROBERT,YANG EDDIE,HELAL CHRISTOPHER JOHN
申请号：
CL2013002125
公开号：
CL2013002125A1
申请日:
2013.07.24
申请国别(地区):
CL
年份:
2013
代理人:
摘要：
The present invention relates to compounds of the Formula and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as a method for the treatment of a disease or condition selected from the group consisting of central nervous system disorders, cognitive disorders, schizophrenia, dementia and other disorders in a mammal.COMPUESTOS DERIVADOS DE IMIDAZO[5,1-F][1,2,4]TRIAZINA, INHIBIDORES SELECTIVOS DE PDE2； COMPOSICION FARMACEUTICA QUE LOS COMPRENDE； Y SU USO PARA EL TRATAMIENTO DEL DETERIORO COGNITIVO ASOCIADO CON EZQUIZOFRENIA Y EL TRATAMIENTO DE MIGRAÑAS.
